Recent developments concerning the DRD Key Indicator in United Kingdom by Corkery, John
  
 
 
 
 
 
 
 
 
 
EMCDDA Meeting on the Key Indicator  
Drug-related Deaths and Mortality among drug users 
 
 
15 October 2014 - Lisbon 
 
 
 
 
Compilation of National Abstracts  
 
 
 
 
Recent developments concerning the Key Indicator in the Member States,  
Candidate Countries and Norway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Recent developments concerning the DRD Key Indicator in Belgium 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
In Belgium, national data on drug-induced deaths are available from the General Mortality Register (GMR). 
Since 1991, the FPS Economy – Directorate-general Statistics and Economic Information, centralizes the data 
from the death certificates coded by the Flemish and French Communities according to the International 
Classification of Diseases, Injuries and Causes of Death (ICD). The 9th edition (ICD-9) was used until 1997. 
From 1998 onwards, the 10th edition (ICD-10) was used. The mortality information is registered on the basis of 
residency (de jure information) as opposed to the region were the death occurred (de facto information).  
The latest national data currently available are from 2003 and 2010. For 2010, 49, 24 and 14 drug-induced 
deaths (Selection B) were observed within the Flemish, Brussels Capital and Walloon region, respectively. For 
2003, the respectively numbers were 43, 24 and 30. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• There are no methodological changes in the 2014 report compared to the 2013 report. 
 
• The Selection B is a very strict selection, and we observe, since 2006, less F-codes in favour of the X and Y 
codes. However, in case of X and Y codes, an additional demand is the combination of the X and Y codes 
with the T400-409 codes. But on the field, the medical doctors rarely mention a T400-T409 code in case of 
X and Y codes. This raises the question to which extent the decrease in drug-related deaths in 2010 is a 
real decrease, or rather a reflection of the coding practices in the field in relation to the strict selection B.  
 
 
3. Emerging concerns 
 
New psychoactive substances are a growing concern with regard to drug related deaths. In 2012 and 2013, 
several deaths occurred in Belgium after the consumption of amphetamine, contaminated with a NPS, in this 
case 4-methylamphetamine. A death has also occurred after the consumption of an ecstasy tablet contaminated 
with PMA and PMMA. Also in 2013, a suspicious death occurred where the drug 25I-NBOMe was detected. 
Contrary to the well-known ‘classical’ drugs, the problems with these NPS is that no information is available with 
regard to toxicity, or treatment in case of overdose. This is a major concern, also in Belgium. On top of that, 
detection of these NPS is difficult, so the possibility exists that NPS were involved in additional deaths, but that 
these remained undetected; as a result, this could underestimate the number of deaths where NPS were 
involved. 
 
 
4. Your 2014 presentations or sessions 
 
Because the new expert recently started, we prefer not to contribute with any presentations or sessions.  
 Recent developments concerning the DRD Key Indicator in Bulgaria 
 
 
1. Brief overall situation on DRD  
 
• Overdoses 
 
In Bulgaria GMR is National Statistical Institute (NSI). 
The total number of deaths from causes related to drug use in 2013 is 21, or 0.29 per 100 000 population. 
Significant difference in deaths by sex. In 2013, the dead men as a result of drug use are 18 or 85.7% of all 
deaths from these causes. The mortality rates by gender were respectively 0.51 per 100 000 males and 0.08 per 
100 000 women. The largest number of deaths related to drug use in the age group 30-34 years - 8 people. The 
majority (90%) of all deaths in young ages - from 20 to 39 years. In 2013 not a single case of death from 
intentional self-poisoning by and exposure to antiepileptic, sedative, hypnotics, antiparkinsonian and 
psychotropic drugs, not elsewhere classified (H61) Intentional self and influence of drugs and psychodysleptics 
[hallucinogens], not elsewhere classified (H62) and Accidental poisoning by and exposure to antiepileptic, 
sedative, hypnotics, antiparkinsonian and psychotropic drugs, not elsewhere classified (H41). The reason is the 
changed national definition and implementation of internationally comparable definition of the EMCDDA, 
selection B. 
 
Two more sources of information have been used as an alternative source of DRD data for 2013 – (1) the 
Forensic Medicine and Deontology Centers (FMDC) in Sofia (Aleksandrovska Hospital) and other cities and (2) 
the Ministry of Interior (MI). The FMDCs have provided data for deaths when autopsy has been done and any 
drug use has been detected. The data has been classified by gender, age, type and quantity of the detected 
substances as well as organs where they were detected. Date of death, the cause and the place of deaths have 
been indicated as well. 42 deaths caused by drug poisoning during 2013 are reported by the FMDCs, only for 
Sofia. The average age is around 33. The Ministry of Interior has provided annual DRD data about all the 
country for 2013 summarized by the administrative regions. Data is classified by gender and by age (in 3 groups 
– under 18; 18 – 30; above 30). However the data does not include the death causes.  
Summarized data for drug related deaths will be available in the Annual Report 2014 of NFP and respective 
Standard Tables. 
 
• Mortality among drug users (cohorts set up, findings, problems...) 
 
Results of mortality data analysis based on a retrospective national mortality study of the treatment demand 
cohort for 10-year period are available. Mortality Rate and Standardized Mortality Ratio estimates are calculated 
and presented in the Standard Table 18 through the National Annual Report 2010. 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• 2013 it’s the first year of implementation of the EMCDDA definition in combination with T-codes and using a 
4-digit code according to ICD-10 causes of death in the structure of deaths by causes changes occur. The 
trend with the largest share are deaths from accidental poisoning by and exposure to narcotics and 
psychodysleptics [hallucinogens], not elsewhere classified (H42), but in 2013 these reasons are due 81% of 
deaths due to drug use. Poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not 
elsewhere classified, undetermined intent (Y12) and two reasons in Class V of ICD-10, "Mental and 
behavioral disorders" are the cause of death in 9.5% of cases of deaths 
 
• In 2013 are registered deaths in 15 treatment programs with agonists and agonist- antagonists, such  (the 
total number is 31 people) According to the reasons, largest number of deaths due to health complications. 
The reports of the programs, reflect for 3 patients - died from an overdose. 
 
3. Emerging concerns 
 
The average age of deaths from causes related to drug use in 2013 was 32.4, down compared to 2012. It is 
higher for men - 33.1, and for women it is 28.3 years. Analyzing the data, however, the small number of cases, 
particularly in relation to the women should be notified and taken into account. 
 
 Recent developments concerning the DRD Key Indicator in Croatia 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
- In Croatia there are two sources of data on the number of drug-related deaths (DRD). The first one being 
the General Mortality Registry (GMR) based on DCs, and the second one the Treated Drug Addicts 
Registry, which among other thing monitors causes of death among drug addicts. Successful cooperation 
between these two registries has made it possible to upgrade data quality. 
- This report has used data from the GMR, applying the “Selection B” protocol for drafting standard ST5 and 
ST6 tables. 
- In 2013, 48 persons died as a direct result of drug abuse (DRD), which is the same number like previous 
year. 42 deceased persons were men (87,5%) and 6 women (12,5%). Average age of the deceased was 
37.4, for men 38 and 34 for women. The decreasing trend in the number of DRDs continued in 2013. 
According to the results of autopsy reports for 2013, opiates are still the predominant type of drug (84%). 
 
• Mortality among drug users  
 
- The Treated Drug Addicts Registry analyzes causes of death among drug addicts. 
 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
No changes since last year. 
 
 
3. Emerging concerns 
 
We do not have new concerns 
 
 
4. Your 2014 presentations 
 
• Title: Overview of DRD and deaths among drug addicts in Croatia  
 
 Recent developments concerning the DRD Key Indicator in Cyprus 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Although the number of overdoses remains low (under 10), recently there have been deaths related to 
oxycodone. Fewer (although very small numbers) heroin overdoses. 
 
• Mortality among drug users  
 
There are no studies on mortality 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
- 
 
 
3. Emerging concerns 
 
• Oxycodone overdoses  
 
 
 
 Recent developments concerning the DRD Key Indicator in the Czech Republic 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Stable situation. Up to 50 cases annually - one third opiates, one third meth, one third volatile substances. One 
year delay in reporting from SMR. SMR and GMR: convergency of total cases of fatal overdoses. 
 
• Mortality among drug users  
 
No new study available. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
See above 
 
 
3. Emerging concerns 
 
Potentially new synthetic opioids. But up to now just potentially. 
 
 
4. Your 2014 presentations or sessions 
 
 
Mortality of drug users in central Asia 
 
An analysis of the mortality of drug users was performed in Central Asia in 2011-2012, the results for Kazakhstan and 
Uzbekistan are presented in detail due to problems with data validity. Indirect standardisation of crude mortality rates 
and construction of standardised mortality ratio (SMR) comparing observed number of deaths with expected number of 
deaths according to age and gender specific mortality rates in the general population of the same country was 
performed. A system of registration of all users of illegal drugs known to the health and/or law enforcement authorities 
(“narcological registers”) was used. The results show excess mortality in registered drug users, particularly in 
registered females. The excess mortality was highest among young adults (18–34) in all the studies. Taking into 
account the limited quality and reliability of the data, the crude mortality rate among registered drug users was quite 
high when compared to EU countries. The SMR in total was comparably lower as a result of the high background 
mortality in the general population. High mortality of females desires targeted programmes.   
 
Mortality of problem gamblers in th Czech Republic 
 
Retrospective database-linkage mortality study of hospitalised problem gamblers in the Czech republic in 1994-2011 
was performed. Indirect standardisation and SMR was computed comparing age and gender specific mortality with that 
of general population in the Czech Republic.  Excess mortality in problem gamblers wa found  - SMR was approx. 2 
over the years, with the structure similar to that in general population except higher proportion of external causes of 
deaths, particularly intentional self-harm (suicides). 
 
 Recent developments concerning the DRD Key Indicator in Estonia 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
The total number of drug-related death declined in 2013 to 111 from 170 in 2012. Toxicology pattern has not 
changed, 96 cases involved fentanyl. Other substances causing overdose were methadone, morphine, cocaine. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Decline in absolute number of overdoses may be due to decline of IDU population suggested by recent studies 
or harm reduction measures, including distribution of naloxone started in september 2013.  
 
 
3. Emerging concerns 
 
-  
 
 
4. Your 2014 presentations or sessions 
 
Drug Overdose Mortality in Estonia, Gleb Denissov.  
 
Estonian DRD rate per population used to be the highest in Europe. This is due to widespread use of fentanyl 
and 3-methyl-fentanyl. These substances are not new, however only in Estonia drug users swithed to them from 
other opiates. Recent decline in DRD numbers may be due to decline in IDU population or efficient harm 
reduction policies, toxicology pattern has not changed. 
 
 
 Recent developments concerning the DRD Key Indicator in Finland 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Opioids continue to be the most important group in fatal poisonings, especially buprenorphine and tramadol. 
 
• Mortality among drug users  
 
Number of drug findings related to drug abuse in medico-legal autopsy cases in Finland. The cause of death can 
be also other than poisoning. 
 
  
2006 2007 2008 2009 2010 2011 2012 
Heroin 2 1 3 3 2 1 3 
Buprenorphine 88 97 104 111 156 150 129 
Cannabis 99 94 93 119 116 124 141 
Amphetamines 64 94 73 94 113 93 114 
Methadone 21 26 33 34 34 27 21 
Cocaine 1 3 3 4 4 2 5 
GHB 6 2 1 11 3 11 20 
Total 191 234 248 256 304 288 309 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• Prescription opioids are even more important in DRDs 
• New abused substances: pregabalin, gabapentin, bupropion 
• Off-label prescription (insomnia, anxiety) of quetiapine for drug addicts is increasing 
 
 
3. Emerging concerns 
 
New psychoactive substances in DRD cases, especially alpha-PVP 
 
 
4. Your 2014 presentations or sessions 
 
Role of pregabalin and gabapentin in opioid overdose deaths 
 
 
 Recent developments concerning the DRD Key Indicator in France 
 
New information 
 
1. Brief overall situation on DRD  
 
According to the available official data, DRDs peaked in 1994 and experienced a sharp drop connected with the 
spread of opioid substitution treatment. However, a new upward trend was detected in 2003 and continued until 
2008. Between 2008 and 2010, DRDs plateaued. In 2011, the number of overdose deaths decreased 
significantly (GMR). The interpretation of these data must remain cautious. Indeed, changes in the rules of 
coding intervened in 2011: the codes F10.0 to F19.0 (only .0 corresponding in acute poisoning) cannot be any 
more used in initial cause and are replaced by X41, X42, X61 according to the product and the context. 
Accordingly, the deaths by overdose of methadone or buprenorphin (coded F11.0 until now) are coded from now 
on X42. 
 
• Overdoses  
 
The lack of adequate detailed information on substances stipulated in the death certificates remains a major 
barrier to a better understanding of this on-going process, supporting the use of special registry (forensic 
laboratories). This special registry showed that methadone was involved for 45% of death from overdose in 
2012, BHD for 15% whereas heroin was involved for 15% and cocaine 12%. It should however be kept in mind 
that this registry does not include all forensic laboratories and that in France toxicological analysis are not 
carried for all cases of overdose death. 
 
• Mortality among drug users  
 
Following the EMCDDA's recommendations, a prospective cohort study, based on treatment centres and a few 
harm reduction facilities, was launched in December 2009. Inclusion was very difficult due to the non 
anonymous inclusion collection. We faced the reluctance of professionals and drug users mainly in the low 
threshold centres. Over 550 centres (135 low threshold centres, 420 treatment centres), 53 voluntarily 
participed. 1000 individuals were included during the first draft which ended in June 2010. A second draft 
included 186 individuals in 2011. Subjects will be followed-up to up to 5 years. The first point to find the vital 
status and cause of death, as applicable was held in July 2013, the second will take place in 2015. Between 
09/2009 and 12/2011,1134 individuals included. 
970 vital status found (ie 86 %) : 77 % are male – 23 % are female.  
37 deaths had occurred in 07/2013 
Causes of death were indicated for 17 individuals (8 deaths in 2010, 11 deaths in 2011) : underlying causes of 
death are : 2 drug intoxications (X44.9), 1 addiction F19-2, 1 road accident (V89), 2 lung cancers (C34), 2 
gastrointestinal bleeding, 1 liver cancer, 1 asthma, 1 alcoholic coma, 2 sudden deaths and 4 unknown causes 
(R99). If the share of deaths mentioning an unknown cause is confirmed when we will recover all the data, there 
will be difficulties in interpreting causes of death. However, we could made hypothesis that the unknown causes 
are suicide or overdose. 
Person years follow-up are 2 949. Crude mortality rate among females is 16.7 person years, CMR among males 
is 11.3. Total CMR is 12.5. SMR among females is 20.82 with wide 95% CI between 10.4 and 37.3. SMR among 
males is 5.2 with 95% CI between 3.4 and 7.7. In a cohort of individuals arrested for drug use between 1992-
2001 in France, SMR among males was similar (SMR was 5.2 with 95% CI between 4.9 and 5.5). SMR among 
females was lower (SMR is 9.5 with 95% CI between 8.0 and 11.3), but the CIs overlapped and it can not be 
concluded that there is a statistically significant difference. 
 One limitation is the lack of knowledge of the substances consumed at death 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
In 2011 the figure of overall DRDs provided by the general mortality registry showed a fall – primarily connected 
with the decrease in the coded F19 cases (Mental and behavioural disorders due to multiple drug use and use of 
other psychoactive substances). In a more detailed analysis, with restricted drug-users' age ranges (i.e. 15-49 
year old), this decrease is still apparent. 
Opioid substitution treatment, in particular methadone is responsible for a greater share of death from overdose 
compared to the previous years (data from SR). 
 
3. Emerging concerns 
 
Consideration of deaths due to cardiovascular and cerebrovascular accidents after cannabis use (data from SR). 
 Recent developments concerning the DRD Key Indicator in Germany 
 
 
1. Brief overall situation on DRD  
 
• Overdoses 
 
- Basing on national definition (special register), the number of direct DRD has increased in 2013 as 
compared with the previous year (+6%) for the first time since 2009. (2012: n= 944; 2013: n=1002) 
- 83% are male, slight decrease of proportion of males since some years but no accelerating new gender 
trend apparent. 
- No relevant change in mean age, since during the last 15 years the mean age increased on average by 6 
months per year 
- - Slight increase of metamphetamine- related deaths from N= 7/9 (monovalent/ polyvalent without opioid 
use) in 2012 to  N= 10/8 in 2013;   single cases of deaths due to new synthetic drugs (monovalent n=3, 
polyvalent without opioid use n=2) 
- Stability in monovalent opioid overdose (+0,4%) and cocaine- associated poisonings, apparent rise in 
polyvalent overdose (+12,3%) 
- Decrease in monovalent methadone overdose (-46% from n=37 to n=20); increase in polyvalent methadone 
overdose (+7,5% from n=146 to n=157) 
- Fentanyl- related overdose decreased significantly. 
 
• Mortality among drug users  
 
No new data since PREMOS study published iin 2011 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
For 2014 there is no apparent new DRD trend so far detectable from some regional data. 
 
3. Emerging concerns 
 
Potential undetected number of DRD due to synthetic subtances.  
Crystal meth abuse in Germany   
 
 
4. Your 2014 presentations or sessions 
 
Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in 
Hamburg from 2007 to 2012           
 
Methadone plays a continous role in drug-related deaths in Hamburg. To find out whether intravenous application of 
methadone plays a relevant role in methadone-related deaths, body fluids of all methadone-positive cases (n=130) and 
three buprenorphine-positive cases where a urine sample was available (n=58+3) were investigated for disaccharides 
(sucrose and lactose as markers for intravenous methadone abuse). Sixty-four percent of the urine samples of the 
methadone cases showed positive results for disaccharides. The three buprenorphine cases showed positive results 
for lactose in urine. In blood, it was not possible to detect any disaccharides. Of the 116 fatal methadone intoxications, 
49 % were under opiate maintenance treatment (OMT) at the point of death (A-OMT), 30 % were never in OMT (N-
OMT) and 21 % were formerly in an OMT, but not at the point of death (F-OMT). Of the deceased in the OMT group, 
12 % (n=7) died within the first 2 weeks of treatment, six of them within the first week. Overall, intravenous abuse of 
methadone plays a relevant role in methadone-related fatal cases of substituted patients and of drug consumers not in 
therapy.  
 Recent developments concerning the DRD Key Indicator in Hungary 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Heroin overdoses disappeared since 2010 as heroin is not available, paralelly there is a minor increase in the 
number of overdoses where methadone is included. Mostly polidrug pattern can be seen including rivotril and 
alcohol. 
As NPS injecting is on the rise, fatal overdoses where NPSs (eg. 5-IT, 4'4-DMAR,) are included are of high 
concern.  
 
• Mortality among drug users  
 
No data available.  
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Several fatal intoxications happened in 2013 and in 2014 due to NPS use. 
 
 
3. Emerging concerns 
 
NPS toxicological data and pathological data are still limited. Laboratories face difficulties when analysing these 
substances in biological samples. Synthetic cannabinoids led to numerous non-fatal intoxications and were 
involved in death cases as well, however, little is known about their role.  
 
 
 Recent developments concerning the DRD Key Indicator in Ireland 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
The National Drug-Related Deaths Index (NDRDI) in Ireland provides all data on drug-induced deaths (DRD) 
and mortality among drug-users in Ireland.   
Data shows a decrease of 22% on DRD reported in 2012 compared to 2011, however the main drugs involved 
remain the same. The percentage of these deaths that involved polysubstances has increased slightly. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• Heroin related deaths continue to decrease since 2009 
• Methadone related deaths are the main cause of DRD in Ireland 
• Cocaine related deaths remain stable however the increase in MDMA related deaths seen in 2011 data is 
maintained 
 
 
3. Emerging concerns 
 
 - 
 
 
4. Your 2014 presentations or sessions 
 
• Presentation 1 
 
Title: Benzodiazepine related deaths in Ireland. 
 
Between 2002 and 2012, there were 1051 poisoning deaths recorded in the National Drug-Related Deaths 
Index (NDRDI) where a benzodiazepine was implicated either alone or with another drug or substance.  
This represents 30% of individual poisoning deaths during that period. The vast majority (98.5%) involved 
polysubstances.    Of those deaths where benzodiazepines were implicated, 75% (n = 790) had only one 
benzodiazepine type implicated, 22% had two types implicated and the remainder three or four. Diazepam 
was the benzodiazepine most frequently implicated in poisoning deaths, followed by flurazepam.  The main 
drugs involved along with benzodiazepines in polysubstances poisonings included; Alcohol 40% (n = 414), 
methadone 38% (n =397), antidepressants 30.5% (n = 316) and heroin 26% (n = 271).  The majority were 
male 69.4% (n = 729). Over one third 34.8% (n = 366) were aged between 25 and 34 years of age. There 
were higher proportions of females in the older age groups and higher proportions of males in the younger 
age groups.  
 
• Presentation 2 
 
Title: Methadone related deaths in Ireland. 
 
The percentage of methadone related deaths has risen sharply from 15% of all NDRDI poisoning deaths in 
2004 to 30.4% in 2011 with a decrease to 24.6% in 2012. The majority 80.3% (n = 552) involve 
polysubstance poisonings. Benzodiazepines are the most common drug group implicated with methadone 
in methadone polysubstance deaths. Of all methadone related deaths in the period 2004 to 2012, 62% were 
with someone at the time of death.   
 
 Recent developments concerning the DRD Key Indicator in Latvia 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
According to the EMCDDA Selection B 11 deaths were recorded in 2013 (17 in 2012, 11 in 2011, 7 in 2010, 19 
in 2009). Out of all deaths in 2013, one was woman and ten were men. According to the State Centre for 
Forensic Medical Examination there were cases when the cause of death was not related to overdose, however, 
drugs were discovered in the biological environments of the deceased. In 2012 in addition to overdose cases 
there were 17 cases when narcotic substances were found in the biological environments of the deceased; in 
2013 there were 12 such cases. 
 
Deaths due to drug use 1996−2012 (absolute numbers) 
 
Source: The Centre for Disease Prevention and Control of Latvia, 2013; State Centre for Forensic Medical Examination, 2013 
 
The average age of deceased females was 34 years while the average age of deceased males — 31 year 
(Selection B). The overall mean age of persons deceased due drug overdose was 31 year. The youngest 
recorded deceased was aged 23, while the oldest was aged 40. Out of all cases accidental poisoning (X41and 
X42) was recorded in nine cases, while in two cases the intention of the person is unknown (Y11 and Y12). 
Substances related with poisonings are following - T40.6 Poisoning by, adverse effect of and underdosing of 
other and unspecified narcotics (in six cases), T40.1 Poisoning by and adverse effect of heroin (in two cases), 
T40.2 Poisoning by, adverse effect of and underdosing of other opioids (in one case), T40.9 Poisoning by, 
adverse effect of and underdosing of other and unspecified psychodysleptics [hallucinogens] (in one case) and 
T43.6 Poisoning by, adverse effect of and underdosing of psychostimulants (in one case). 
 
As stated in National reports there are two major sources for DRD data collection in Latvia: 1) General Mortality 
Register (GMR) held at the Centre for Disease Prevention and Control of Latvia, 2) Special Register held at the 
State Centre for Forensic Medical Examination.  On annual basis the two institutions compare their database 
and check for inconsistencies.   
 
• Mortality among drug users  
 
There has been conducted a study in 2013, where 1 709 (8,085.1 person-years) registered primary 
amphetamine users (users registered from 2000 to 2012) were analyzed. Data suggests that amphetamine 
users have a higher mortality rate than observed in the general population. There were observed 61 deaths 
among 1 709 amphetamine users (or 3.6%). Observed mortality rate (CMR - crude Mortality rate) was 7.6 per 
1,000 person-years (8.2 per 1000 PY among men and 5.4 per 1,000 women). In comparison with general 
population mortality rate among women and men was 8.1 times and 2.9 times higher accordingly. 
 
 
 2. 2014 analysis (what is new since the 2013 national report?)  
 
Routine data about DRD in the mortality register suggests drug-related deaths are much lower than for 
neighbouring Baltic countries.  On the other hand the number of performed autopsies is on decrease (e.g. in 
2007 authopsies were performed in 19.7% of total number of deaths as compared with 15.3% in 2012) thus 
suggesting there might be many cases, for which underlying cause of deaths is not reported correctly.  The latter 
is further supported also by the data from the mortality cohort study, which suggests mortality rates among 
treated and untreated drug users is not that different from those obtained in other countries/cities.  Moreover 
there are many patients for whom diseases from circulatory, respiratory or other somatic problems are registered 
as the underlying cause of death. 
 
 
3. Emerging concerns 
 
In the beginning of 2014 was the first time that head shop drugs (presumably synthetic cannabinoids, Spice) 
were suggested to be linked with case of death (according to information from media). However it must be noted 
that we don't have an official approve for this due to unable to detect these drugs by toxicological analyses. The 
number of performed autopsies is continuously decreasing from 19.7% of total number of deaths in 2007 to 
15.3% in 2012 which may be one of the reasons for DRD underestimation.     
 
 
4. Your 2014 presentations or sessions 
 
Recent DRD trends in Latvia 
 Recent developments concerning the DRD Key Indicator in Lithuania 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
The national “drug related death“ definition used in this chapter for data presentation are almost the same as the 
EMCDDA standard definition for the General Mortality Registries ICD-10  Selection B. The national drug-related 
death definition aims death cases, where the main death cause was marked in the death certificate with one of 
these ICD-10 codes: F11; F12; F14; F15; F16; F18, F19 ; X42; X62; Y12, the national definition does not include 
cases with ICD codes X41, X61, Y11 with  T40 codes.  
During reported year was registered 54 deaths cases (45 males and 9 females) due to drugs and psychotropic 
substance use. Compared to 2012 was noticed decrease on Drug-related deaths in Lithuania and this level 
accounts for 0,13 percent of all deaths registered in Lithuania (in 2012 – 0,17 percent). 
 
• Mortality among drug users  
 
Lithuania collects data regarding persons registered in the health care institutions due to mental and behavior 
disorders using drugs and psychotropic substances (ICD codes: F11-14, F15, F18, F19). 
In 2013, 65 individuals registered as patients dependent on drugs and psychotropic substances died, i.e. 61 men 
and 4 women 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
After some increase in death cases due to drug and psychotropic substance use noticed in 2012, an decrease of 
drug-related death cases was registered in 2013 in Lithuania (Table 3-1). 
 
Table 3-1. Number of deaths caused by drug and psychotropic substance use, by age 2009-2013 
Age group 2008 2009 2010 2011 2012 2013 
Under 15 - - 1 0 0 0 
15–19 years 1 - 0 1 1 3 
20–24 years 10 6 12 6 9 3 
25–29 years 22 24 9 14 21 13 
30–34 years 6 16 10 10 16 16 
35-39 years 11 10 11 6 8 14 
39 years and more 10 12 8 8 15 5 
Total 60 68 51 45 70 54 
Information Source: the Department of Statistics under the Government of the Republic of Lithuania (data until 2010) and the 
Institute of Hygiene (data from 2010) 
 
 
3. Emerging concerns 
 
In 2013, the number of deaths of individuals registered as patients dependent on drugs and psychotropic 
substances increased (2012 - 42, 2013 - 65). As before, in 2013, among the deaths the biggest number was 
opioid dependent persons - 50. 
 
 
4. Your 2014 presentations or sessions 
 
No presentation  
 
 Recent developments concerning the DRD Key Indicator in Luxembourg 
 
 
 
1. Brief overall situation on DRD  
 
In Luxembourg there is a legal obligation to contact the Judicial Police in cases of suspicious death, death under 
suspicious circumstances or death in public spaces. The Drug Unit of the Judicial Police runs a special register 
indexing overdose cases at the national level. So far, this special register is the most accurate information 
source available. The National Toxicological Laboratory (LNS - Laboratoire national de santé) is contacted by 
the Specialized Drug Unit of the Judicial Police to provide forensic analyses. After a cross-check of information, 
we know that in 2013, 12 cases were reported by Police and a total of 11 overdose cases were verified after 
autopsy in Luxembourg.    
 
• Overdoses  
 
Most cases (with one exception) involve a mixture of multiple substances. Opioids have been detected in all drd 
(8 involve heroin, the other 3 methadone or mephenon). Other substances such as alcohol and prescription 
drugs were also reported in all toxicological analyses. 
 
• Mortality among drug users  
 
Mean age of victims is 36.9, the youngest victims were 30 (one female and one male) and the oldest 53 years 
old (male). Female average age is slightly lower than male average age (33.2 vs 39). Figures suggest that 
females' "drug carrer" is shorter than males' career. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
No "new" or striking change regarding previous years. The number of victims is slightly higher than the 2 
previous years but is still stable (11 in 2013, 8 in 2012, 6 in 2011 and 14 in 2010).3 bullet points 
 
 
3. Emerging concerns 
 
"New/novel substances" have not been identified in relation to drd.  Main concern remains the mixture (cocktails) 
of different (illegal but also legal such as alcohol and prescription for instance neuroleptic, anxiolitic) drugs.  
 
 
 
 Recent developments concerning the DRD Key Indicator in Malta 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
During the year 2013 there were 3 drug related deaths, a decrease from the previous year of 2. There were 2 
male and 1 female deaths and mean age of death was 31.5 years.  They were coded as intentional poisoning 
and the drug of abuse was mainly heroin. 
 
 
• Mortality among drug users  
 
Malta is currently participating in a mortality cohort study which is being coordinated by EMCDDA. The study 
was based on a treatment centre mainly for heroin users followed up from 1994 to 2008. There were 1805 
subjects followed up with mean age at enrolment of 24 years. Results of this study are being analysed. 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
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The above graph shows the trend in the number of DRDs since the year 1991. The trends must be interpreted 
with caution given the small numbers. There was no significant yearly difference in the number of drug related 
deaths over the period 1991-2013 (p= 0.16).   The mean age of death for the period 1991-2013 is also shown in 
the graph above. There was a significant increase in the mean age of death (p= 0.04) as also visualised through 
the above trend line. 
 
 
3. Emerging concerns 
 
• No new problems. 
 
 
 
 Recent developments concerning the DRD Key Indicator in Norway 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Since the peak in DRDs in 2000/2001 there has been a decrease, and the 2012 number of 246 deaths in 
Norway seems to be a continuation of the trend in recent years. The decrease in DRDs has coincided with 
higher availability of opioid maintenance treatment (OMT) during recent years. Although a decrease since the 
2000 peak, the number of DRDs is still high in Norway. Reasons for the high frequency may be several; In 
Norway injecting of drugs is prevalent and typically drugs are taken in a poly-drug fashion. Additionally a 
relatively high post mortem frequency of the DRDs including toxicological investigations in Norway allows high 
rates of detection of DRDs.   
OMT is increasingly available and currently more than 7055 patients are in treatment (likely 50-60% of target 
population) as the treatment system has become less restrictive and more harm reduction oriented in recent 
years.  
Opioids and particularly heroin dominate the overdose situation.  
 
 
• Mortality among drug users  
 
A cohort study is currently including at treatment intak, target is 500 included by mid 2015, and follow-ups will be 
performed with interview at one year and further follow-ups by registry linkages is planned.  
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• Methadone related deaths on a steady increase since 2009, now nearly as common as heroin-deaths 
• Opioid maintenance treatment institutions should focus on a safety regarding take-home medication 
particularly with methadone patients 
• A nasal naloxone project has been initiated in 2 cities; Oslo and Bergen 
• The Minister of health and social affairs has lanced a national overdose prevention campaign   
 
 
3. Emerging concerns 
 
Increasing numbers of methadone related deaths. Less overdose-reduction than anticipated during recent years 
although rapid expansion of OMT. Povidone related deaths have been reported associated with injection of 
Martindale methadone (oral liquid) in Norway. Martindale methadone has therefore been withdrawn from the 
Norwegian market during spring of 2014.  
 
 
 
 Recent developments concerning the DRD Key Indicator in Portugal 
 
1. Brief overall situation on DRD  
 
In 2013, the mode of data collection has not changed.  
Following a strategic recommendation of the Action Plan on Drugs 2009-2012, as well as the implementation of 
procedures to improve the quality of general mortality registries - new circuits for data transmission and the 
transition to ICD-10 from 2002 -, Portugal began to privilege the general registries in the context of this indicator. 
Simultaneously we intensified the work on optimizing the information of specific registries (complementing the 
information of toxicology and pathology reports in order to determine the cause of death in cases with 
toxicological positive results). 
As a result of the work undertaken in 2008 and 2009 concerning specific registries records it was possible to 
provide information from specific registries on overdose cases. Portugal filled in 2010 the Questionnaire on 
Special Registries on drug related death in Europe, providing detailed information on national specific registries. 
In a near future this information will contribute to improve the national mortality statistics in this area and will now 
overcome some constraints related to statistical secrecy in the provision of toxicological information and social 
demographic in the context of national mortality registries of INE (National Statistics Institute). 
In the General Mortality Registry we couldn’t give the break down by ICD Codes (Numbers), but we could 
determine the codes and combination of codes. 
In 2013, started the implementation of the medical certificate online. 
 
• Overdoses  
 
Data from general mortality register 2013 still not available.  
In special mortality register 2013:  
In 2013, in the context of autopsies, from the 184 deaths with information on the cause of death (75% of the 
cases with positive toxicological results), 22 (12%) were considered overdoses (29 overdoses (16%) in 2012 and 
19 overdoses (12%) in 2011).  
Concerning the substances detected in these cases of overdoses once more opiates were predominant (46%). 
Cocaine was detected in 36% of the cases. As occurred in previous years the majority (91%) of these overdose 
cases was detected more than one substance (76% in 2012, 79% in 2011 and 87% in 2010), considering the 
associations with illicit and/or licit substances. In 2013, the majority (82%) of overdose cases are from the male 
gender (97% in 2012, 84% in 2011 and 88% in 2010) being the mean age 42 years old (37 in 2012, 38 in 2011 
and 39 in 2010). 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Nothing to report.  
 
3. Emerging concerns 
 
In 2013 were registered three cases of overdose involving synthetic drugs in combination with other drugs. Two 
cases involving Ecstasy and one case involving methcathinone in combination with ephedrine. In 2012 and 2011 
only one case involving synthetic drugs was registered in each year. 
 
4. Your 2014 presentations or sessions 
 
Prevalence of benzodiazepines in postmortem cases in 2013 
In Portugal in 2012 psychotropic drugs represented 49% of the sale of drugs with action on the central nervous 
system. In 2012 anxiolytics / sedatives and hypnotics presented a DDDs/1000 inhabitants/day > 80, a trend that 
keeps over the past 10 years. Different trend shows the use of antipsychotics drugs that in same period reveals 
in 2012 a value of DDDs/1000 inhabitant/day four times higher than in 2002. 
This high consumption of drugs is also reflected in cases of intoxication. According to data from the Portuguese 
Anti Poison Center 65% of intoxication in adults are associated with medicines and among these drugs 66% 
were psychodrugs. 
In last year 80% of cases received in the Department of Forensic Toxicology of the INMLCF, were requested for 
screening of medicines. The analytical protocol included approximately 100 active substance distributed by 
various pharmacotherapeutic subgroups. Among the positive cases, the benzodiazepines are the more 
prevalent, alone or in combination with ethanol and others drugs. Distribution by gender, age and type of 
combinations drugs are presented. 
 Recent developments concerning the DRD Key Indicator in Romania 
 
1. Brief overall situation on DRD  
 
The data collected under DRD are taken over from the body of forensic cases, the forensic medicine institutions 
being the only ones empowered to manage such cases. Once defined as such, for all the forensic cases 
toxicological investigations are carried out. The forensic autopsy files -18942 cases this year-form the selection 
basis for Special Mortality Register where drug related deaths are recorded. In 2013, the indicator DRD shows a 
slight decrease in the total number of drug related deaths registered compared to the previous year. The number 
of deaths directly    attributable to drug use returns to values close to the numbers reported in 2007-2010, years 
of stabilisation in drug use and patterns. The number of indirect deaths has decreased to almost half of the value 
registered in 2012, comparable to the period 2007-2010. 
 
• Overdoses  
 
In 2013 there were 30 cases of direct drug related deaths recorded, from which: 
- 28 cases from Bucharest, one case from  Arad and another one from Ilfov; 
- 25 men and 5 women; 
- average age for direct DRD - 31,3 years (13 cases from the 30-34 years old group); 
- administration route: most of the direct DRD cases were intravenous opioids injectors(24), 4  cases were 
cannabis smokers and 2 cases of cocaine oral users. 
- substances used: - 23 from all 30 direct DRD were methadone users (76,7%) - 25 methadone overdoses 
from all drd cases.  
o 2 cases of cocaine users; 
o 1 case of ephedrine associated with some other medicines; 
o 1 case of NPS combined with opiates, 
o 3 cases of intoxication with psycholeptics (barbiturates &benzodiazepines). 
As a conclusion, in 2013 statistics show that direct DRD in Romania are obvious consequences of methadone 
use (76,7%). In almost all cases (21 of the 23 cases) methadone was combined with sedatives (zolpidem, 
citalopram, topiramat) and benzodiazepines and also with alcohol and canabinoides ( 4 cases).  
There is also an increasing trend of drug use combined with alcohol ( 8 cases in 2013 compared to 2 cases in 
the previous year). Methadone was identified in 3-4 times over the toxic-lethal range concentration in most of the 
cases. In 2 cases the concentration was 10 times over this limit. 
  
• Mortality among drug users  
 
The number of drug related deaths remains stable, comparable to values registered in 2007-2010. 
It is quite probable a  significant underreporting due to the fact that some INDIRECT death associated to drug 
use cases were not registered in the Special Mortality Register database because of their definition which 
exceeds the criteria for the mandatory forensic analysis. 
Injecting use remains the main route of administration for drug related deaths and the opiates are the most 
frequent substances used, with an alarming increase of methadone use (medicine under strict control in 
Romania). 
Incidence peaks of drug related deaths are registered during the summer time of 2013.  
No mortality cohort studies were conducted this year.  
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• Decreasing trend of NPS use -the main cause for indirect deaths in the former 2 years and also an important 
factor for infectious pathology (HVB, HVC) increase among IDUs. 
• "old" substances responsible for direct drug related deaths reappeared (tramadol, cocaine). 
• 9 drug related deaths were reported from the medical emergencies database (6 in 2012). 
 
3. Emerging concerns 
 
• allarming increase of methadone use  incidence (25 of the 30 cases of direct deaths reported) 
• allarming increase of hiv incidence among IDUs 
• the urgent need to improve the data collection sistem ( legal definitions of drug related deaths in Romania, 
expanding  the laboratories and testing facilities network, implementing a specific software aplication for data 
colection for DRD, international exchange of good practices in DRD case management and so on) 
 
 Recent developments concerning the DRD Key Indicator in Slovakia 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
52 deaths caused by the direct effects of psychoactive substances were reported in 2013. The important 
proportion of these were caused by opioides only - 14 cases and by opioides in combination with various 
substances – 9 cases, which represents together 85% of all direct deaths caused by illicit drugs and solvents. 
Another 25 deaths (48%) of all direct deaths were caused by medicines. Other substances excluding opioides 
were identified in 4 cases (14%).  
 
• Mortality among drug users  
 
          No data available      
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Reported numbers of DRD in 2013 in Slovakia are very similar to the year 2012; 52 and 50 DRD respectively. 
Tramadol was detected in 18 cases of direct deaths i.e. in 78% of deaths connected with opiates/opioides and in 
4 cases of indirect deaths.  
 
 
3. Emerging concerns 
 
There were not realized recent specific analyses or studies on drug-related mortality except of routine data 
collection and evaluation in the year 2013. 
 
 
 Recent developments concerning the DRD Key Indicator in Slovenia 
 
 
 
1. Brief overall situation on DRD  
 
In 2013 there was no signifficant difference in the number of deaths in comparison to the number of deaths 
during the last few years. Splitted by five years age groups the highest number of deaths by groups was moving 
towards the older ages, but in 2013 returned back to the 30-34 age group as was in 2010 and 2011.  
Heroine and methadone were drugs responsible for the majority of deaths as a consequence of unintentional-
accidental poisonings. Deaths of undetermined ( hether accidental or suicidal) intend were on the second place 
of which the highest share could be unintentional poisonings, as was the case in a cohort study. No suicides by 
drugs occured in 2013. On average during the last ten years the number of men wictimes of illicit drugs were five 
and a half time higher than women. There were different mortality rates of direct drug poisonnings with different 
share within three intention cathegories in different regions. No specific indices that drug situation is getting 
better, except median age at death which is increasing from year to year, were observed. 
 
Figure 1  Percent share of death among illicit drug users included ( cohort data) or not ( GMR data) in the 
methadone maintenance treatmen by month of death, Slovenia 2004-2013. 
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Source: IPH (Medical dath certificate - IPH 46 
 
It is evident that during the colder months of a year people not included in the methadone maintenance treatment 
die frequently than in the period from June to September.  
 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
“Causes of death among young drug users in Slovenia during the period 2004-2012”, a presentation on Slovene 
scientific conference about caring with and treatment of persons using new drugs, Ljubljana February 2014. 
Drug related mortality in Slovenia. Differences between deceased treated and untreated illicit drug users. Heroin 
Addict Clin Probl 2013; 15(1):29-38. 
 Two scientific papers dealing with suicides among drug users on methadone maintenance therapy and drug 
users not in treatment were sent for publishing. The answers have not been received yet. 
Ph D thesis on “Suicides among drug users on treatment” is in finalization. 
 
 
 
 
 
 3. Emerging concerns 
 
In the year 2013 there were no deaths due to new psychoacitve substances, but intoxications with some of 
them: MDMA, 3MMC (drug spread the most among drug users) GHB, andGBL were admitted to hospitals, 
(intoxications by GHB, GBL were life-threatening). Due to the the increasing threats encountered, the activities 
of Early Warning System (EWS) were intensified, trying to make a network of EWS local points reporting to the 
EWS central with the aim to react properly and in time according to the recommendations accepted. Assessing 
the drug situation on the base of direct deaths and cohort data we assume it is relatively stable. In spite of cohort 
data there is a gap on the number and causes of indirect deaths among drug users not in treatment. We hope 
special register will be established again in the next years. 
 
The most important conclusions we made after ten years follow up of the cohort data, were: 
• after 10 years of follow up the incidence of mortality or mortality rate of treated drug users was 5,7  
deceased /1000 person years 
• mortality rate of drug users being in treatment was in men two times higher than that of Slovene men of the 
same age group but in women even 2,5 times higher that meant that women drug users in treatment were 
doing worse than men in comparison to corresponding population, 
• after eight years decreasig of mortality rates and years of potential life lost YPLL, both were increasing in 
the last two years. 
• mortality risk of clients in the first year of treatment was 1,55 higher than that of those being in treatment 
longer, 
• also in drug users in treatment living alone or being unemployed or not included in school system carry a 
higher risk of death than living with someone or being student or earn some money.  
• The most direct cause of death was unintentional poisoning with heroine and/or methadone, but among 
indirect deaths alcohol liver chirrosis and cardiovascular diseases prevailed. 
 
Higher risk of death, lower age at death, and higher number of potential years of life lost per deceased in the 
cohort together with causes of death point to a need of treatment as early as possible after the drug career 
starts.  
 
 Recent developments concerning the DRD Key Indicator in Spain 
 
 
1. Brief overall situation on DRD  
 
• More info available    
o http://www.pnsd.msssi.gob.es/Categoria2/observa/home.htm  
o http://www.emcdda.europa.eu/html.cfm/index214091EN.html. 
 
• Sources of information 
Two sources of information are currently being used in Spain:   
o Specific Death Registry due to acute reactions to drugs.   
o General Death Registry (National Institute of Statistics)  
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Spanish trends and situation   
• Looking at data from the estimated number of deaths from illegal drug use at a National level from 1983 to 
2011, it is observed that, after the peak at in the early 1990s, a downward trend has occurred and it looks it 
is become stable. In 2011, a total of 387911 deaths occurred in Spain, of which it has been calculated that 
736 were caused by the non-medical use of illegal substances. 
• In 2011, opioids were the substance identified in most deaths (77.9%), hypnosedatives remained as the 
second most prevalent substance (65%), changing the downward trend that began in 2005 
Hypnopsedatives are showing a sudden increase and outnumber figures for cocaine, which occupied 
second place during the 2002-2009 period. Cocaine has retained the downward trend that began in 2007 
(67%), and was present in 52.2% of deaths in 2011.  
• The figure below shows the evolution of deaths due to severe reactions after the use of psychoactive 
substances in Spain, from 1983 to 2011. The data presented correspond to the percentage of deaths in 
which each of the substances or metabolites referred to were identified in toxicological analyses.  
 
3. Emerging concerns 
 
• Polydrug use is the most frequent pattern for these deaths due to a severe reaction to psychoactive 
substances.   
• Increase of the presence (it is not possible to attribute causality) of cannabis in the death related with drugs.  
 
.  
 
4. Your 2014 presentations or sessions 
 
Spain can make a short presentation showing the trends of mortality due to illegal drugs and some basic 
characteristics of the deaths (sex, age, civil state, previous pathology, suicide, HIV serology)  
 
 Recent developments concerning the DRD Key Indicator in Sweden 
 
 
 
1. Brief overall situation on DRD  
 
• Overdoses  
 
Continued increase in DRD for the seventh consecutive year. Data from Toxreg show increase from heroin, 
buprenorphine, amphetamine and THC, whereas methadone decrease.   
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
• Many of the deaths reported in the CDR turn out not to be drug induced, but may be an outcome from the 
high number of autopsies and analysis performed.  
• More analyses are needed to find out how the CDR and toxicity register can show the same amount of 
deaths as the when the Toxreg list ALL cases tested positive for drugs. 
 
 
3. Emerging concerns 
 
• Is heroin use increasing?  
• Officials show increased interest in the DRD increase that hopefully can lead to increased efforts.  
 
 
 
 Recent developments concerning the DRD Key Indicator in The Netherlands 
 
 
4. Brief overall situation on DRD  
 
• Overdoses  
 
Due to technical coding issues, data for 2013 from the Causes of Death Statistics from Statistics Netherlands 
(CBS) will not be available until October/November 2014. 
 
 
5. 2014 analysis (what is new since the 2013 national report?)  
 
- 
 
6. Emerging concerns 
 
We trust that Statistics Netherlands will succeed in progressing to automatic coding. 
 
 
7. Your 2014 presentations or sessions 
 
- 
 
 Recent developments concerning the DRD Key Indicator in Turkey 
 
 
1. Brief overall situation on DRD  
 
In 2013 compared to the previous year, a 43.2% increase was observed in the number of direct DRDs. In 2013 
compared to the previous year, a 155% increase was observed in the number of direct DRDs (n:416). Cases of 
intoxication with opium derivatives decreased 5.8% compared to the previous year. Compared to the previous 
year, the cases of non opioid drug related deaths increased significantly.  The rate of using cocaine increased 
166.7% in indirect drug related deaths and 52.6% in direct related deaths compared to 2012.  Both in cases of 
direct (n:58) and indirect DRDs (n:94), a very significant increase is being observed in ecstasy use compared to 
the previous years. The rate of using cannabis increased 162.2% in indirect drug related deaths and 67.6% in 
direct related deaths compared to previous year. There has been a slight increase in the average age of men 
among the direct DRD cases compared to previous year.  The rate of men below 19 years of age among the 
direct DRD cases of men in 2012 was (n:15) 9.3% whereas this rate increased to (n:25) 11.1% in 2013. Among 
the indirect DRD cases; however, there has been a dramatic decrease in the average age of men compared to 
previous year (2012: 35,5; 2013: 32,8). While the age groups in 2013 direct DRD cases in order of frequency are 
25-29, 20-24, 35-39, 30-34, 15-19, 40-44 (in 2012 20-24, 25-29, 30-34, 35-39, 15-19); indirect DRD cases in 
order of frequency are 20-24, 25-29, 30-34, 35-39, 15-19, 40-44 (in 2012 25-29, 20-24, 35-39, 30-34, 15-19).  
 
• Overdoses  
 
162 cases of direct DRDs were observed in Turkey in 2013. %70.7 (n:164) of deaths caused by intoxication with 
opium derivatives (heroin in 46 cases, heroin and alcohol in 6 cases, heroin ve methadon in 1 case, heroin ve 
tramadol in 1 case, heroin ve fentanyl in 1 case, methadon in 2 cases, heroin and other drugs in 107 cases), and 
29.3% (n:68) of deaths caused by intoxication with other drugs (ecstacy in 12 cases, ecstacy and alcohol in 1 
case, cocaine in 2 cases, cocaine and alcohol in 2 cases, amphetamine in 1 case, JWH-018 in 1 case, JWH-018 
and alcohol in 2 cases, volatile substance in 8 cases, volatile substance and alcohol in 1 case, poly drug use in 
38 cases). 
 
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
The use of synthetic cannabinoid was detected 15,1% (n:35) of the direct DRD cases, 14,7% of the indirect DRD 
cases. However, synthetic cannabinoid can be analyzed only 4 out of 10 labs. Therefore, this data cannot reflect 
the real number. 2- The use of opium derivatives except heroin has increased. In the direct DRD cases 
methadone in 3 cases, tramadol in 1 case and fentanyl in 1 case were detected; whereas, in the indirect DRD 
cases methadone in 1 case was found. 3- The number of cities where the indirect DRD cases take place has 
shown an increase of 35,1% and rose to 50 (the total number of cities: 81). 
 
 
3. Emerging concerns 
 
There has been a considerable decrease in the average age of the indirect DRD cases compared to previous 
year. The age of drug use has been decreasing. 2- There has been an increase in the number of deaths related 
to the use of non opioid drugs. 3- Poly drug use has increased. Most of the direct DRD cases are related to poly 
drug use. 
 Recent developments concerning the DRD Key Indicator in United Kingdom 
 
New information 
 
1. Brief overall situation on DRD  
 
Using the DRD Standard, there were 1,946 deaths registered in the UK in 2013 (1,666 in 2012, up 16.8%); 
males 76.0%, females 24.0%. Males are generally about 5 years younger than females. Most deaths occurred in 
the 40-44 age-group. The number of deaths per 100,000 population (all ages) shows that differences exist 
between the different countries within the UK. Thus, in 2013 the rate using the DRD Standard was 9.62 in 
Scotland compared to 2.40 in England & Wales and 3.55 in Northern Ireland. The UK average was 3.04 in 2013 
(1.98 in 1996). Overall, the largest proportion of deaths in England & Wales using the wider ONS definition was 
described in 2013 as accidental poisoning (1862/2955 - 63.0%), followed by intentional/undetermined poisonings 
(970 or 32.8%), and then mental & behavioural disorders (121 or 4.1%). Males are more likely to die at a 
younger age of drug dependence/non-dependent abuse of drugs and females at an older age by means of 
intentional/undetermined poisoning. 
 
In England & Wales in the period 1993-2013, more than one drug was involved in 32.9% [18949/57583] and 
alcohol in 26.1% [15029/57583] of all DRDs (using the wide definition employed by ONS). Deaths in 2013 where 
heroin/morphine was mentioned numbered 765 (up from 579 in 2012, but up from 155 in 1993). The number of 
cases in which methadone was implicated rose steadily from 206 in 1993 to peak at 437 in 1997, falling to 199 in 
2002, before rising to a new peak of 408 in 2009; but fell back to 355 in 2010 before reaching an all-time high of 
486 in 2011 and then declining to 429 in 2013.  Mentions of cocaine, although still comparatively few compared 
to heroin/morphine, rose more than 20-fold over the period 1993-2008 as a whole (from 11 to 235) but fell to 202 
in 2009 and 112 in 2011 before increasing again in 2013 to 169. Deaths involving ecstasy accounted for only 1% 
of drug-related deaths; they rose from 12 in 1993 to 56 in 2002, fell to 43 in 2004, rose again to 58 in 2005, but 
fell to 27 in 2009 and to only 8 in 2010 (the lowest since monitoring started) but recovered to 43 in 2013. 
GHB/GBL were mentioned in 76 deaths recorded by the ONS between 1996 and 2009, and had followed a 
rising trajectory in the last few years, but fell in 2009-2010 before rising in 2011 only to fall back in 2012 but 
rising again in 2013 to 18. Mentions of piperazines started to appear on death certificates in 2009 (n=9) and 
2010 (n=5) but fell in 2010 (n=6) and 2011 (n=2), but rose to 9 in 2012 before falling to 1 in 2013. Cathinones 
such as mephedrone made their first appearance in 2010 (n=6), remaining at that level in 2011 before 
quadrupling to 26 in 2013.  
 
2. 2014 analysis (what is new since the 2013 national report?)  
 
Over the period 1996-2001, the total number of deaths rose by 73.2% from 1,152 to 1,995; fell by 20.1% to 
1,595 in 2003, and then increased by 39.9% to 2,231 in 2008, before falling by 25.3% to 1,666 in 2012, followed  
by a rise to 1946 in 2013. There were rises of 52.8% and 153.8% for males and females respectively over the 
period 1996 to 2013. There was a male: female ratio of 3.2:1 in 2013. Using the broad ONS definition, the 
overall number of deaths fell by 3.5% between 2010 and 2011 and by 2.1% between 2011 and 2012, before 
rising by 9.3% in 2013 to a new peak. Table 1 shows, during the last year, an increase in the number of deaths 
involving mephedrone (+57.1%), ecstasy-type (+40.9%), amphetamine (+26.9%), cocaine (+23.6%), 
heroin/morphine (+22.6%), paracetamol (+22.0%), tramadol (+19.7%). There were falls in the number of 
mentions of cannabis (-27.8%), temazepam (-22.2%), diazepam (-9.0%), methadone (-1.5%), anti-depressants 
(-1.1%), and anti-psychotics (-0.7%) recorded. 
 
Published data show there were 46 deaths associated with Volatile Substance Abuse in 2009 (38 in 2008). This 
is the second lowest figure since data collection methods became stable in 1983 and compares with the all-time 
peak of 152 in 1990 (Ghodse et al, 2012b). In addition, there were 46 deaths resulting from the inhalation of 
helium, compared to 26 in 2008. No updates have been possible due to a lack of resources at the UK SMR 
(NPSAD). 
 
Deaths of IDU (including sex between men and IDU) AIDS victims accounted for 7.9% (1,512/19,186) of the total 
number of AIDS deaths in England & Wales up to the end of December 2012. The levelling off in the number of 
deaths of IDU AIDS victims seen in recent years gave way to a slight increase in 2009. The UK figure of 63 for 
2011 (66 in 2010) is about 30% of the peak level in 1995 (212). By the end of December 2012, 46 deaths had 
been reported for that year (Personal communication to John Corkery from Health Protection Agency, 30 May 
2014).  
 
 Table 1: Mentions of selected drugs on death certificates, United Kingdom, 2003-13 
 
Year 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Drug            
Heroin/morphine 883 977 1,045 985 1,130 1,230 1,215 1,063 820 825 1011 
Methadone 292 300 292 339 441 550 586 535 765 660 650 
Cocaine 161 192 221 224 246 282 239 181 152 174 215 
Amphetamine 43 53 62 60 62 72 57 52 72 67 85 
Ecstasy-type 66 61 75 62 64 52 32 9 24 44 62 
Mephedrone 0 0 0 0 0 0 1 14 9 14 22 
Cannabis 32 24 25 22 20 20 22 11 7 18 13 
All benzos, of 
which 427 385 321 297 345 414 442 469 514 527 535 
Diazepam 282 216 210 187 223 277 302 315 336 410 373 
Temazepam 114 88 55 56 57 50 48 38 45 45 35 
Antidepressants 524 565 484 454 436 512 528 528 529 618 611 
Antipsychotics 77 94 96 104 114 117 110 116 143 148 147 
Paracetamol 547 632 490 376 306 319 302 251 257 223 272 
Tramadol 51 56 75 109 116 126 135 185 205 254 304 
All ONS definition 
deaths 3,168 3,378 3,305 3,306 3,352 3,754 3,677 3,517 3,499 3,436 3,755 
Notes: A revised data collection form was introduced in Scotland in 2008 which has resulted in more specific drugs 
being identified than in previous years; ONS revised how they deal with paracetamol in compounds in 2010, and 
revised their figures retrospectively. ONS have made revisions to their historic data; data for Northern Ireland have 
been extracted for us by NISRA and are slightly different in some years to what had been previously extracted. Year of 
registration of death, not year when death occurred. 
 
 
3. Emerging concerns 
 
In an attempt to assist in a better understanding of the extent of NPS use and the fatalities that have been linked 
to these compounds Elliott and Evans (2014) collated their findings in post-mortem and criminal casework where 
these have been detected and/or implicated. Between January 2010 and December 2012 NPS were detected in 
203 cases, with 120 cases in 2012 alone. The drugs detected in ‘in vivo’ or post-mortem blood and urine were, in 
order of decreasing frequency: mephedrone, 4-methylethcathinone, BZP, MDPV, TFMPP, methoxetamine, 4-
fluoromethcathinone, 4-methylamphetamine, PMA, methylone, PMMA, naphyrone, alpha-methyltryptamine, 
butylone, MDAI, desoxypipradrol, D2PM, MPA, synthetic cannabinoids, 2-AI, 5-IAI, 5-MeODALT, MDPBP, 5/6-
APB, pentedrone and pentylone. Other drugs or alcohol were detected in 84% of the cases including other NPS. 
Figure 1: Comparison of total number of deaths using three definitions, 
UK, 1996-2013
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 In respect of fatalities it should be noted that alternative causes of death (including mechanical suicide, 
accidental death and non-psychoactive drug overdose) accounted for the majority. Related to this was that of all 
fatalities involving cathinones, 41% of these were hangings or other mechanical suicides, this was a higher 
proportion than seen with other drugs found in such cases. The presence of multiple NPS and/or other 
stimulants was a particular feature in various cases, however, of the drug deaths only 7% solely involved NPS. 
Across all case types and including some cases investigated in 2013, NPS concentrations showed a wide range 
but these and selected cases are presented to assist  toxicological interpretation in future cases. 
A cluster of deaths in Northern Ireland occurred during 2013 and several of these were associated with the 
police seizure of tablet items (“Speckled Cherry” and “Speckled Cross” motifs). Analysis of both tablet types 
revealed the presence of a new designer drug which was characterized as para-methyl-4-methylaminorex (4,4’-
DMAR) or “Serotoni”. Although 4-methylaminorex and aminorex are controlled Drugs in the UK, the para-methyl 
derivative is not subject to control at this time. The presence of 4,4’-DMAR was detected in toxicology samples 
submitted in a number of drug abuse deaths; some of which were directly associated with the tablet seizures. By 
May 2014, the drug had been detected (in blood/urine/gastric contents) in a total of 18 fatal cases in Northern 
Ireland. (Cosbey et al. (2014). In all of these cases at least one other drug was also detected. Excluding two of 
the cases, where the drug concentrations were very low (0.02 mg/L), post mortem concentrations of 4,4’-DMAR, 
ranged from 0.20 to 3.75 mg/L (median 1.18 mg/L). There are indications that this drug may have also been 
involved in 8 fatalities in another European country. 
Handley and Flanagan (2014) used published statistics from the Office for National Statistics (Mortality Statistics 
– Injury and poisoning, Series DH4 (2000 – 2005), Mortality Statistics – Deaths registered in England and 
Wales, Series DR (2006 – 2011), and the Office for National Statistics drug poisoning database for information 
on fatal poisoning during 2000 – 2011); and 7 papers that gave relevant information on deaths reported during 
2000 – 2011 that were not superseded by later publications (identified from Pubmed for ‘fatal’ and ‘poisoning’ 
and ‘England’ and ‘Wales’), found the annual number of deaths from poisoning fell from 2000 (3092) to 2010 
(2749), before increasing to 3341 in 2011. This increase was due in part to a change in the ICD coding relating 
to alcohol poisoning, suggesting that such deaths had been under-recorded previously. Although fatalities from 
dextropropoxyphene declined (287 in 2004 and 18 in 2011) following the withdrawal of co-proxamol 
(paracetamol [acetaminophen] and dextropropoxyphene [propoxyphene] mixture) during 2005 – 2007, deaths 
involving codeine and most notably tramadol (836 deaths during 2000 – 2011) increased. Deaths from 
paracetamol poisoning either alone, or with alcohol reached 89 in 2011, the lowest annual figure since 1974. 
However, in reality there has been no marked downward trend since 1999 despite reductions in pack size, 
continued publicity as to the dangers of paracetamol overdose, and improved liver failure treatment, including 
transplantation. The annual number of deaths from antidepressants remained relatively stable (median: 397, 
range: 335 – 469). Although the number of deaths from dosulepin [dothiepin] decreased (186 in 2000 and 49 in 
2011), the number of deaths involving selective serotonin reuptake inhibitors increased (50 in 2000 and 127 in 
2011). Although annual numbers of deaths involving diamorphine/morphine (88% unintentional) declined, deaths 
involving methadone (89% unintentional) increased and the total annual number of deaths from these drugs 
showed little change (2000: 1061, 2011: 995). Deaths involving amphetamine/methylamphetamine remained 
relatively constant at about 50 annually, and whilst cocaine-related deaths fell by 48% during 2008 – 2011, and 
deaths involving MDMA and related compounds fell by 69% over this same period, deaths involving ‘legal highs’, 
notably Gamma-hydroxybutrate/ Gamma-butyrolactone and ketamine, increased. The authors conclude that 
alterations in the availability of paracetamol and of prescription drugs such as dextropropoxyphene and 
dosulepin have not been accompanied by decreases in the number of deaths from poisoning. Despite intense 
media and other interest, the annual number of deaths (250 – 300) involving ‘recreational’ drugs remains small 
in relation to the 1000 or so deaths a year from heroin/morphine and/or methadone. 
In the UK tramadol is a frequently prescribed opioid analgesic which is becoming increasingly popular as a drug 
of misuse. A review of all deaths associated with tramadol highlighted 127 cases from 1996-2012 (Randall and 
Crane, 2014). A 10% increase in such deaths was noted. In 2001 tramadol deaths represented nine per cent of 
all drug misuse deaths rising to 40% in 2011. The majority of deaths occurred in males (62%), with a median 
age of 41 years, living in the Belfast city area (36%). Tramadol deaths were observed in combination with other 
drugs/medicines (49%), alcohol (36%) or alone (23%). Most of those who died did not reach hospital, with only 
2% presenting with multi-organ or acute liver failure.In just over half of the deaths, tramadol had not been 
prescribed by a medical practitioner (53%). Depression, anxiety and seizures were recognised as risk factors. 
The authors noted that an increase in awareness of tramadol toxicity is needed amongst the public and doctors. 
 
Weich et al. (2014) used a retrospective cohort study of 273 UK primary care practices contributing data to the 
General Practice Research Database, covering 34,727 patients aged 16 years and older first prescribed 
anxiolytic or hypnotic drugs, or both, between 1998 and 2001, and 69,418 patients with no prescriptions for such 
drugs (controls) matched by age, sex, and practice. Patients were followed-up for a mean of 7.6 years (range 
0.1-13.4 years). After excluding deaths in the first year, there were approximately four excess deaths linked to 
 drug use per 100 people followed for an average of 7.6 years after their first prescription. The authors conclude 
that in this large cohort of patients attending UK primary care, anxiolytic and hypnotic drugs were associated 
with significantly increased risk of mortality over a seven year period, after adjusting for a range of potential 
confounders.  
 
4. Emerging problems: new substances, characteristics of victims… 
 
Legal highs/Novel psychoactive substances (NPS) 
Whilst opiates and opioids continue to dominate in the UK, towards the end of 2009 there was a noticeable 
decline in the number and proportion of cases involving stimulants. To some extent these changes appear to 
have been reversed slightly for amphetamines and ecstasy-type drugs. Substances such as piperazines, 
ketamine and GBL which at the time of the 2009 report were ‘legal highs’ but became controlled drugs, continue 
to be present in post-mortem toxicology reports - although possibly declining in the case of piperazines. Towards 
the end of 2009 new substances, chiefly methcathinones such as mephedrone started to appear in reports to 
np-SAD. These increased during 2010 and into 2014. As these became controlled, new substances emerge; of 
particular concern at present are phenazepam and other ‘designer’ benzodiazepines, PMA/PMAA, 4,4’-DMAR, 
benzofurans, indoles, synthetic cannabinoids, synthetic opioids.  
 
ICD coding 
Towards the end of 2009 new substances, chiefly methcathinones (such as mephedrone, methylone and 
MDPV), and naphyrone started to appear in reports to np-SAD and are still occurring. In addition new classes of 
substances, such as aminoindanes, benzofurans, indoles, methoxetamine and synthetic cannabinoids have 
caused fatalities. The past few years have seen some important changes in the types of drugs being used 
recreationally and consequently beginning to contribute to drug-related morbidity and mortality. The UK expert 
has discussed with the GMRs difficulties in respect of ICD-10 coding for novel psychoactive substances/’legal 
highs’ for which there are no specific codes or guidance. These points have been relayed in these last few years 
to the EMCDDA in Lisbon, and fed into the discussions of the WHO body drawing up ICD-11.  
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A record-linkage study of opioid-related deaths and treatment for opioid misuse in England 2008-2011  
The high mortality rate of opioid users has received wide research attention, in particular the levels of drug-related 
death in those who engage in structured treatment.  In the present study, information concerning 220,665 adults who 
received structured treatment for opioid misuse in England between April 2008 and March 2011 is matched to 
England’s drug-related mortality database.  Using national estimates of opioid prevalence to provide a base population 
of opioid users, rates of opioid-related poisoning are calculated outside (or prior to) treatment, during treatment and 
after treatment.  Estimated additional numbers of opioid-related poisonings in the absence of treatment are calculated 
by applying rates outside treatment to all opioid users.  We suggest that triangulating prevalence, treatment and 
mortality data provides an effective method that could be used to evaluate the efficacy of treatment systems in 
reducing opioid-related poisoning.   
 
A record-linkage study of drug-related deaths and drug misuse treatment in England 2007-2011 
The high mortality rate of drug users has received wide research attention, in particular the levels of drug-related death 
in those who engage in structured treatment.  In the present study, information concerning 350,039 adults who 
received structured treatment for drug misuse in England between 2007 and 2011 is matched to England’s drug-
related mortality database.  The primary aims of this study are to identify any periods of increased risk during or 
following treatment and to explore which key factors may increase or mitigate risk of drug-related death, analysing 
information collected throughout treatment on levels of drug use and other individual risk covariates such as 
homelessness or regular employment.  These findings could enable the application of mortality prevention measures 
within treatment services and this could ultimately facilitate a reduction in drug-related death among individuals in 
contact with drug treatment. 
